Mastopexy Market Synopsis:
Mastopexy Market Size Was Valued at USD 1.45 Billion in 2023, and is Projected to Reach USD 2.39 Billion by 2032, Growing at a CAGR of 5.70% From 2024-2032.
Breast lift, also known as mastopexy, is a cosmetic surgical operation aimed at surgically correcting exercises breastptosis to improve their position, firmness, and overall appearance by the removal of inferior skin, resection of underlying tissue to achieve better tone and adjustment of the nipple position. This procedure is typical of women who complain of breast ptosis caused by other factors such as aging, weight loss, pregnancy, or family genes. As an independent procedure it is also possible to combine it with breast augmentation or reduction depending on the desired final outcome and the patient’s body shape.
The need for the Mastopexy Market has been driven by the growing popularity of breast surgery among females. As people’s aesthetic expectations change with time and more folks getting into careers where excellent looks are vital, procedures like mastopexy thus becomes popular. Moreover, increased attention to the prevention of the disease and psychological achievements as a result of breast surgeries also enhance the market’s development. Self-esteem and self-perception are also important facet of patient demand that patients are demanding breast lift.
The increase in surgical innovations and improved treatment utility after surgery also drive the Mastopexy Market. Advancements in technology have involved a shift in the approaches used in surgery and a shift in anesthesia practices to mention but a few. In addition, the availability of enhanced imaging techniques also facilitates better pre-optimization and execution of operations. These enhancements not only enhance the Mastopexy patients’ safety but also fuel the market growth further for Mastopexy procedures.
Mastopexy Market Trend Analysis:
The rising acceptance of breast lift procedures among younger demographics.
- One trend obtainable in the Mastopexy Market is the increasing popularity of breast uplift among younger populations. In most cases, mastopexy was performed by women of advanced ages; but increasingly more, women of young age are seeking these surgeries to retain perky breast shapes. The change is attributed to social media in as much as we have many people who openly discuss their cosmetic surgery procedures hence raising awareness, and encouragement for aesthetic procedures at a tender age.
- They note additional trend as frequent combined with breast lift surgery and body sculpting operations like liposculpture and abdominoplasty. Aging patients want to improve their looks and therefore multiple procedures services are required causing plastic surgeons to popularize combinations that improve body aesthetics. This is also in conjunction with the growing incidence of health-conscious individuals who desire to gain proportional bodies hence fanning the growth of the mastopexy market.
The growing geriatric population presents
- The increasing number of geriatric populations is a good growth factor for the Mastopexy Market. Changes due to ageing include loss in the elasticity and shape of the breast; thus, older women are looking for remedies for this problem. Surgeons can meet this demand by providing services targeted at this demographic and making available information concerning the merits of mastopexy. Additionally, the pressure to look young increases the number of women over the age of 50 considering adjustments for the practitioner raising the potential number of patients.
- Further, consumer interest in mastopexy procedures can be expected to rise in emerging markets of Asia-Pacific and Latin America. With this the disposable incomes in these regions will improve and so as the knowledge on the cosmetic surgeries and therefore we are likely going to record an increase in the number of people likely to undertake the breast lift surgeries as being among the best options for improving their looks. That’s why, both companies and healthcare providers should use this trend to their benefit and establish detailed marketing campaigns and introduce convenient payment plans for patients to draw more customers.
Mastopexy Market Segment Analysis:
Mastopexy Market is Segmented on the basis of Type, Procedure, Material, End User, and Region
By Type, Full Mastopexy segment is expected to dominate the market during the forecast period
- There are two specific breast lift operations known as full mastopexy and partial mastopexy that can tackle breast prolapse. For the full mastopexy it entails a complete procedure of which, apart from lifting the breasts they are reformed through excision of the extra skin, relocation and possibly resizing of the nipple. This approach is usually considered for ladies who have a lot of looseness or for those ladies who want an enhanced remodeling of their bust. Partial mastopexy, as the name suggests only addresses particular region of the breast rather than the whole breast unit. This approach works well for people with mild to moderate breast ptosis who wish to reshape their breast without the need for a full mastopexy. These two operations focus on enhancing the morphology of the breast and increasing self-esteem, according to the specifics of female anatomy and set goals for surgery.
By Material, Silicone Implants segment expected to held the largest share
- There is also various filler used in mastopexy, these includes silicone implant, saline implant and autologous tissue, each of which comes with its benefits. There are two types of silicone implants; the newer silicone implants are filled with a cohesive silicone gel that has seamlessly captured the feel of the natural breast tissue and feels more like natural breast tissue. They are especially used together with mastopexy for the augmentation of breasts especially in women who desire a fuller bust. Then we have the saline types that are filled with water and can be easily changed to the required size during the surgical operation. They normally come as implants and are then filled once in position; they therefore can be inserted through very small cuts and the sizes can fit more accurately but they are not as natural as silicone. Autologous tissue means the use of client’s own tissue with the purpose of creating a natural lift; this tissue is usually sourced from the abdomen or thighs. From this method, it can result in long-term success and fewer problems connected with implants making the process a favorable one for some patients. All options are made based on personal tastes, esthetics, and any health issues a particular person has.
Mastopexy Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- The Mastopexy market is currently led by North America since there are many factors that support the region which include high disposable incomes, a booming industry of cosmetic surgery and well-developed health care facilities. The people in the region have demonstrated a good market for esthetics procedures because of the rising importance placed in physique and self-esteem. The largest concentration of mature markets, recognized plastic surgery clinics and experienced surgeons also contribute to the leadership role of North America in this particular market of mastopexy.
- Similarly, the United States of America as a market in North America has recorded an increased demand for annual breast lift surgery. Features like having adequate insurance, popular advertisement of the beauty services, increased number of cosmetic professionals strengthen the market in the given region. These trends indicate that North America is apt to retain its dominance in the Mastopexy Market for the near future, primarily due to the continuing improvements in the field of surgical procedures and the increasing societal acceptance of the underlying processes.
Active Key Players in the Mastopexy Market:
- Allergan (Ireland)
- Johnson & Johnson (United States)
- Galderma (Switzerland)
- Medytox (South Korea)
- Hugel (South Korea)
- Revance Therapeutics (United States)
- Medytox (South Korea)
- Ipsen (France)
- Sientra (United States)
- Mentor Worldwide (United States)
- Other Active Players
|
Mastopexy Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.45 Billion |
|
Forecast Period 2024-32 CAGR: |
5.70 % |
Market Size in 2032: |
USD 2.39 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Procedure |
|
||
|
By Material |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Mastopexy Market by Type
4.1 Mastopexy Market Snapshot and Growth Engine
4.2 Mastopexy Market Overview
4.3 Full Mastopexy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Full Mastopexy: Geographic Segmentation Analysis
4.4 Partial Mastopexy
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Partial Mastopexy: Geographic Segmentation Analysis
Chapter 5: Mastopexy Market by Procedure
5.1 Mastopexy Market Snapshot and Growth Engine
5.2 Mastopexy Market Overview
5.3 Traditional Mastopexy
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Traditional Mastopexy: Geographic Segmentation Analysis
5.4 Scarless Mastopexy
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Scarless Mastopexy: Geographic Segmentation Analysis
Chapter 6: Mastopexy Market by Material
6.1 Mastopexy Market Snapshot and Growth Engine
6.2 Mastopexy Market Overview
6.3 Silicone Implants
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Silicone Implants: Geographic Segmentation Analysis
6.4 Saline Implants
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Saline Implants: Geographic Segmentation Analysis
6.5 Autologous Tissue
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Autologous Tissue: Geographic Segmentation Analysis
Chapter 7: Mastopexy Market by End User
7.1 Mastopexy Market Snapshot and Growth Engine
7.2 Mastopexy Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals: Geographic Segmentation Analysis
7.4 Ambulatory Surgical Centers
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
7.5 Specialty Clinics
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Specialty Clinics: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Mastopexy Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 ALLERGAN (IRELAND)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 JOHNSON & JOHNSON (UNITED STATES)
8.4 GALDERMA (SWITZERLAND)
8.5 MEDYTOX (SOUTH KOREA)
8.6 HUGEL (SOUTH KOREA)
8.7 REVANCE THERAPEUTICS (UNITED STATES)
8.8 IPSEN (FRANCE)
8.9 SIENTRA (UNITED STATES)
8.10 MENTOR WORLDWIDE (UNITED STATES)
8.11 OTHER ACTIVE PLAYERS
Chapter 9: Global Mastopexy Market By Region
9.1 Overview
9.2. North America Mastopexy Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Type
9.2.4.1 Full Mastopexy
9.2.4.2 Partial Mastopexy
9.2.5 Historic and Forecasted Market Size By Procedure
9.2.5.1 Traditional Mastopexy
9.2.5.2 Scarless Mastopexy
9.2.6 Historic and Forecasted Market Size By Material
9.2.6.1 Silicone Implants
9.2.6.2 Saline Implants
9.2.6.3 Autologous Tissue
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals
9.2.7.2 Ambulatory Surgical Centers
9.2.7.3 Specialty Clinics
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Mastopexy Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Type
9.3.4.1 Full Mastopexy
9.3.4.2 Partial Mastopexy
9.3.5 Historic and Forecasted Market Size By Procedure
9.3.5.1 Traditional Mastopexy
9.3.5.2 Scarless Mastopexy
9.3.6 Historic and Forecasted Market Size By Material
9.3.6.1 Silicone Implants
9.3.6.2 Saline Implants
9.3.6.3 Autologous Tissue
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals
9.3.7.2 Ambulatory Surgical Centers
9.3.7.3 Specialty Clinics
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Mastopexy Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Type
9.4.4.1 Full Mastopexy
9.4.4.2 Partial Mastopexy
9.4.5 Historic and Forecasted Market Size By Procedure
9.4.5.1 Traditional Mastopexy
9.4.5.2 Scarless Mastopexy
9.4.6 Historic and Forecasted Market Size By Material
9.4.6.1 Silicone Implants
9.4.6.2 Saline Implants
9.4.6.3 Autologous Tissue
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals
9.4.7.2 Ambulatory Surgical Centers
9.4.7.3 Specialty Clinics
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Mastopexy Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Type
9.5.4.1 Full Mastopexy
9.5.4.2 Partial Mastopexy
9.5.5 Historic and Forecasted Market Size By Procedure
9.5.5.1 Traditional Mastopexy
9.5.5.2 Scarless Mastopexy
9.5.6 Historic and Forecasted Market Size By Material
9.5.6.1 Silicone Implants
9.5.6.2 Saline Implants
9.5.6.3 Autologous Tissue
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals
9.5.7.2 Ambulatory Surgical Centers
9.5.7.3 Specialty Clinics
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Mastopexy Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Type
9.6.4.1 Full Mastopexy
9.6.4.2 Partial Mastopexy
9.6.5 Historic and Forecasted Market Size By Procedure
9.6.5.1 Traditional Mastopexy
9.6.5.2 Scarless Mastopexy
9.6.6 Historic and Forecasted Market Size By Material
9.6.6.1 Silicone Implants
9.6.6.2 Saline Implants
9.6.6.3 Autologous Tissue
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals
9.6.7.2 Ambulatory Surgical Centers
9.6.7.3 Specialty Clinics
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Mastopexy Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Type
9.7.4.1 Full Mastopexy
9.7.4.2 Partial Mastopexy
9.7.5 Historic and Forecasted Market Size By Procedure
9.7.5.1 Traditional Mastopexy
9.7.5.2 Scarless Mastopexy
9.7.6 Historic and Forecasted Market Size By Material
9.7.6.1 Silicone Implants
9.7.6.2 Saline Implants
9.7.6.3 Autologous Tissue
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals
9.7.7.2 Ambulatory Surgical Centers
9.7.7.3 Specialty Clinics
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Mastopexy Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 1.45 Billion |
|
Forecast Period 2024-32 CAGR: |
5.70 % |
Market Size in 2032: |
USD 2.39 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Procedure |
|
||
|
By Material |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
